Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2025-03-31
• Last 15 days FTD volume: €8.78 M
• Last 3 months FTD volume: €16.56 M
• Last year FTD volume: €16.56 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	€9.92 M	€35.82 M	🇺🇸 USA
Royalty Pharma RPRX	€16.49 M	€42.86 M	🇬🇧 UK
Palatin Technologies PTN	€0.67 M	€3.54 M	🇺🇸 USA
Eli Lilly LLY	€47.82 M	€0.19 B	🇺🇸 USA
AbbVie ABBV	€23.9 M	€0.21 B	🇺🇸 USA
Pfizer PFE	€33.22 M	€0.35 B	🇺🇸 USA
ANI Pharmaceuticals ANIP	€0.25 M	€4.58 M	🇺🇸 USA
Athersys ATHX	€0.09 M	€0.71 M	🇺🇸 USA